Analysts forecast that Care.com Inc (NYSE:CRCM) will post sales of $52.23 million for the current quarter, according to Zacks. Three analysts have made estimates for Care.com’s earnings, with the highest sales estimate coming in at $52.28 million and the lowest estimate coming in at $52.20 million. Care.com reported sales of $49.16 million in the same quarter last year, which would suggest a positive year over year growth rate of 6.2%. The business is expected to announce its next quarterly earnings report on Thursday, November 14th.
On average, analysts expect that Care.com will report full-year sales of $207.20 million for the current financial year, with estimates ranging from $207.02 million to $207.37 million. For the next financial year, analysts expect that the business will report sales of $223.90 million, with estimates ranging from $222.80 million to $226.03 million. Zacks Investment Research’s sales calculations are an average based on a survey of research analysts that follow Care.com.
Care.com (NYSE:CRCM) last announced its earnings results on Tuesday, August 6th. The information services provider reported $0.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.08 by $0.01. Care.com had a negative net margin of 7.61% and a positive return on equity of 7.81%. The business had revenue of $51.00 million during the quarter, compared to analysts’ expectations of $52.20 million. During the same quarter in the prior year, the company posted $0.14 earnings per share. The firm’s revenue was up 10.9% on a year-over-year basis.
A number of brokerages have commented on CRCM. Craig Hallum reiterated a “hold” rating and issued a $9.00 price target (down previously from $15.00) on shares of Care.com in a research note on Wednesday, August 7th. TheStreet cut shares of Care.com from a “c” rating to a “d+” rating in a research note on Wednesday, August 7th. Zacks Investment Research cut shares of Care.com from a “buy” rating to a “hold” rating in a research note on Monday. BTIG Research upgraded shares of Care.com from a “neutral” rating to a “buy” rating and set a $13.00 price target for the company in a research note on Wednesday. Finally, ValuEngine upgraded shares of Care.com from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Five research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average target price of $12.20.
CRCM stock traded up $0.72 during trading hours on Thursday, reaching $10.06. The stock had a trading volume of 1,256,357 shares, compared to its average volume of 574,409. The stock has a market capitalization of $298.16 million, a PE ratio of 27.94, a price-to-earnings-growth ratio of 121.33 and a beta of 0.92. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.85 and a quick ratio of 2.85. The stock has a 50-day simple moving average of $10.64 and a 200 day simple moving average of $16.33. Care.com has a fifty-two week low of $7.61 and a fifty-two week high of $25.81.
In related news, insider David Krupinski sold 3,052 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The shares were sold at an average price of $14.37, for a total transaction of $43,857.24. Following the transaction, the insider now directly owns 152,303 shares of the company’s stock, valued at $2,188,594.11. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Sheila Lirio Marcelo sold 9,805 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was sold at an average price of $14.37, for a total transaction of $140,897.85. Following the transaction, the chief executive officer now directly owns 1,221,974 shares in the company, valued at $17,559,766.38. The disclosure for this sale can be found here. Insiders sold 21,273 shares of company stock worth $305,693 over the last three months. Insiders own 28.10% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. Aperio Group LLC bought a new position in Care.com in the 2nd quarter valued at about $37,000. Pacer Advisors Inc. acquired a new stake in Care.com during the second quarter worth about $79,000. BNP Paribas Arbitrage SA grew its holdings in Care.com by 82,800.0% during the first quarter. BNP Paribas Arbitrage SA now owns 4,145 shares of the information services provider’s stock worth $82,000 after acquiring an additional 4,140 shares during the period. Tower Research Capital LLC TRC purchased a new position in Care.com during the second quarter worth approximately $89,000. Finally, Oppenheimer Asset Management Inc. boosted its position in Care.com by 192.8% during the first quarter. Oppenheimer Asset Management Inc. now owns 4,732 shares of the information services provider’s stock worth $94,000 after purchasing an additional 3,116 shares in the last quarter. 85.99% of the stock is currently owned by institutional investors and hedge funds.
Care.com, Inc operates an online marketplace for finding and managing family care in the United States and internationally. The company helps families to address their lifecycle of care needs, including child care, senior care, and special needs care, as well as other non-medical family care needs, such as pet care, tutoring, and housekeeping; and enables caregivers to find full-time and part-time employment opportunities.
Read More: What is a Roth IRA?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Care.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Care.com and related companies with MarketBeat.com's FREE daily email newsletter.